Watch the recorded session of our webinar that explores the shift in payer perspectives in response to increased R&D efforts toward orphan products.
We conducted interviews specifically for this webinar to ask payers how they thought the orphan drug market will evolve in terms of pricing, reimbursement and market access, and what manufacturers should consider in their orphan drug development strategy going forward.
You will learn:
- An overview of the Orphan Drug Act and events occurring since its passage
- Challenges in orphan drug development
- Reimbursement case studies
- Payer interview findings from Australia, France, Germany, Italy, Spain, the UK, and the US
- Strategic recommendations for orphan drug manufacturers